Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kim (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea), M. Song (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea). Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: Real world experiencefrom a tertiary university hospital. 1848

Member's Comments

No comment yet.

Related content which might interest you: Antithrombotics in idiopathic pulmonary fibrosis patients with concomitant antifibrotic therapy: a single centre real world experience Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Real world idiopathic pulmonary fibrosis in the EMPIRE registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres Source: International Congress 2016 – IPF treatment II Year: 2016 Real life patient experience of pirfenidone in a regional interstitial lung disease clinic Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Frequency of chronic pulmonary aspergillosis in patients treated for pulmonary tuberculosis at a tertiary care hospital in Karachi, Pakistan. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Mortality outcomes in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a real world study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Cost-effectiveness of an early supported discharge service (ESDS) for chronic obstructive pulmonary disease (COPD) in a university hospital serving a large rural population Source: Annual Congress 2007 - Ethical and economic choices in respiratory care Year: 2007 Idiopathic pulmonary fibrosis and systemic sclerosis-interstitial lung disease: features at admission to a tertiary pulmonology unit. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Differing clinical courses of IPF at an acute district general hospital Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Late Breaking Abstract - Effectiveness and tolerability of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) from a large Italian practice cohort Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Acute exacerbation of ILD: an Indian tertiary centre experience Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Effects of programed education for chronic obstructive pulmonary disease on tertiary teaching hospital Source: International Congress 2019 – Medical education Year: 2019 Costs of the patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease in a tertiary university hospital of Turkey Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Interstitial lung disease at a district general hospital: When are patients referred to tertiary care? Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Clinical profile of pulmonary hypertension at a tertiary care centre, India Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013